IPC | Legal Framework, Background and Annotations

  • Version
  • Download 5760
  • File Size 908.38 KB
  • File Count 4
  • Create Date 15 May 2023
  • Last Updated 14 June 2023

IPC | Legal Framework, Background and Annotations

PREFACE
In healthcare facilities, Infection Prevention and Control (IPC) requires a scientific approach to prevent harm caused by infection to patients and healthcare workers. Healthcare-acquired infections (HAIs), which include healthcare-associated antimicrobial resistance (HAI-AMR), are a major threat to health and safety. First, health systems have an ethical duty to “do no harm” when patients receive medical care and the responsibility to protect their employees, volunteers, and visitors. This is an issue of urgency given the expansion of universal healthcare in Africa. Second, Member State signatories to the African Charter on Human and Peoples’ Rights have obligations, including under Article 16, to protect the health of their people. Third, healthcare facilities accelerate and amplify emerging infectious diseases, such as COVID-19 and Ebola. Preventing such infections through the implementation of a routine IPC programme can help limit disease transmission during community outbreaks. Fourth, healthcare facilities help drive emergence and transmission of antimicrobial resistant (AMR) infections, due to the heavy use of antimicrobial agents in the treatment of infections. Effective IPC programmes can reduce the prevalence of AMR infections in hospitals.

As such, healthcare facilities play a key role in effective preparedness and response. By ensuring IPC standards are implemented appropriately, healthcare facilities can provide safe services not only on a daily basis but also when there is a surge in healthcare need.

Attached Files

FileAction
IPC | Legal Framework, Background and Annotations - ENGDownload
IPC | Legal Framework, Background and Annotations - FREDownload
IPC | Legal Framework, Background and Annotations - PORDownload
IPC | Legal Framework, Background and Annotations - SPADownload

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.

We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH

Publication date: October 2024

Download Files
FileAction
African Vaccine Manufacturing Mapping | Supply and Demand LandscapeDownload